NIMH: Non-Competitive Combined Synopsis/Solicitati

The National Institutes of Health, Office of Logistics and Acquisition Operations, seeks bespoke induced pluripotent stem cell (iPSC) quality control and differentiation services, with quotations due September 2, 2026 at 1730 EDT. This is a non-competitive, unrestricted acquisition conducted under FAR 12.603 authority for commercial items, not expected to exceed the simplified acquisition threshold.

Delivery is required to multiple locations. Evaluation will consider price, technical capability, past performance, and delivery schedule, with award going to the responsible offeror representing best value to the Government. All offerors must be actively registered in SAM.gov and provide unit and total pricing, shipping and handling costs, delivery period after award, delivery terms, F.O.B. point, product and service descriptions, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. Responses must be submitted via SAM.gov webportal or email. The NAICS code is 541380, Testing Laboratories and Services; PSC is R499, Support – Professional: Other.

The Government reserves the right to accept any offer before the expiration date. A written notice of award issued within the time specified in the offer constitutes a binding contract. All applicable FAR provisions and clauses in effect through Federal Acquisition Circular 2026-01 (effective March 13, 2026) will be included in the resultant contract. Contact Brittany May, Contract Specialist, at Brittany.may@nih.gov.